Luciana L. Borio

Senior Fellow for Global Health

Expert Bio

Luciana Borio is a senior fellow for global health at the Council on Foreign Relations (CFR). She also is a venture partner at Arch, a venture capital firm that provides seed/early-stage venture capital for technology firms in information technology, life sciences, and physical sciences. Dr. Borio specializes in biodefense, emerging infectious diseases, medical product development, and complex public health emergencies.

Dr. Borio was formerly (2019-2021) the vice president at In-Q-Tel, an independent, non-profit, strategic investment firm that works to identify, adapt, and deliver innovative technology solutions to support the missions of the United States Intelligence Community. She also previously served as director for medical and biodefense preparedness at the National Security Council (2017-2019), where she coordinated the response to the Ebola epidemic in West Africa, efforts to combat antimicrobial resistance, and the development of an Executive Order to modernize America's influenza vaccines. Prior to that, she served as the acting chief scientist of the U.S. Food and Drug Administration (2015-2017), and the assistant commissioner for Counterterrorism Policy of the FDA (2010-2017). Dr. Borio is an adjunct assistant professor of medicine at Johns Hopkins University (2003-present).

Dr. Borio obtained her MD from George Washington University, completed a residency in internal medicine at New York-Presbyterian/Weill Cornell Medical Center, and a combined fellowship in infectious diseases at Johns Hopkins and critical care at the National Institutes of Health. She continues to practice medicine, part-time, at Johns Hopkins.

affiliations

ARCH Venture Partners, venture partner
CEPI, Scientific Advisory Board, member
Eagle Pharmaceuticals, board member
Goldman Sachs, consultant
Insulet, board member
Johns Hopkins University School of Medicine, assistant professor of medicine (part-time)
Nuclear Threat Initiative, board member
Noblis, board of trustees, member

Explore More on Public Health Threats and Pandemics

Public Health Threats and Pandemics

Fentanyl and the U.S. Opioid Epidemic

Opioid addiction has become one of the United States’ biggest killers, endangering public health, the economy, and national security. But closing the floodgates on fentanyl poses a significant foreign policy challenge.

Backgrounder by Claire Klobucista and Mariel Ferragamo December 22, 2023

Drug Policy

The President’s Inbox Recap: The Fentanyl Epidemic

Precursor chemicals from abroad are fueling America’s fentanyl epidemic.

Blog Post by Michelle Kurilla June 2, 2023 The Water's Edge

India

The Quad’s Longevity Might Hinge on Its Health Plan

Even though China might have spurred the Quad’s initial health response, the answer to its longevity lies in building sustainable future coordination.

Article by Manjari Chatterjee Miller May 30, 2023 Asia Program

Expert Bio

affiliations

Global Health Update

Updates from the Global Health program on the program’s latest publications and global health writing from around the web. Quarterly.

More CFR Experts

Thomas J. Bollyky

Yanzhong Huang

David P. Fidler

Explore More on Public Health Threats and Pandemics

Top Stories on CFR